Article
Role of estrogen receptor variants in the development of hormone resistance in breast cancer.
Clinical biochemistry - 1 Dec 1992
Sluyser M
Abstract excerpt
Recent evidence suggests that the progression to hormone resistance in some breast tumors is due to mutations in the estrogen receptor (ER). Various types of ER variants have been found in breast cancer biopsies and breast cancer cell lines. The ER variants include dominant-positive receptors that are transcriptionally active in the absence of estrogen, and dominant-negative receptors that are themselves...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
